Highlight: BRCA1 and BRCA2 proteins in breast cancer

Dianne C Daniel1

  • 1Mount Sinai School of Medicine, Department of Pathology, New York, New York 10029, USA. dianne.daniel@mssm.edu

Insights

Individuals with BRCA1 or BRCA2 gene mutations have increased breast and ovarian cancer risks. These genes are crucial for DNA repair, transcription, and cell growth, with emerging roles in ubiquitin ligase activity and chromatin remodeling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Germline mutations in BRCA1 and BRCA2 genes confer a predisposition to breast and ovarian cancers.
  • BRCA1 and BRCA2 gene products are tumor suppressors involved in inhibiting neoplasia progression.
  • These genes play roles in genome repair, transcription, and growth control.

Purpose of the Study:

  • To highlight recent findings on BRCA1 and BRCA2 functions in breast cancer.
  • To discuss the roles of BRCA1 and BRCA2 in DNA repair, transcription, and cell cycle control.
  • To explore the emerging roles of BRCA1 in ubiquitin E3 ligase activity and both genes in chromatin remodeling.

Main Methods:

  • Literature review of recent findings on BRCA1 and BRCA2.
  • Analysis of proposed functions including genome repair, transcription, and growth control.
  • Investigation of potential ubiquitin ligase and chromatin remodeling activities.

Main Results:

  • BRCA1 and BRCA2 mutations increase susceptibility to breast and ovarian cancers.
  • Evidence suggests BRCA1 possesses ubiquitin E3 ligase activity.
  • Both BRCA1 and BRCA2 are implicated in chromatin remodeling through protein partnerships.

Conclusions:

  • BRCA1 and BRCA2 play multifaceted roles in preventing cancer development.
  • Ubiquitin ligase and chromatin remodeling activities may be key functions of BRCA1 and BRCA2.
  • Further research is needed to fully elucidate the mechanisms of BRCA1 and BRCA2 in breast cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...